Federico Migliore

Plain English
This study looked at how Italian cardiologists manage the first episodes of atrial fibrillation (AF), a common heart condition that can lead to serious problems like stroke. Out of 706 cardiologists surveyed, 81.4% used a risk scoring system to decide on blood-thinning treatments, and 88.9% ordered an echo test after the first AF episode. The findings show a notable variety in treatment approaches across different hospitals, which suggests that better adherence to established guidelines could lead to improved care for patients. Who this helps: Patients experiencing their first episode of atrial fibrillation.

Plain English
This study looks at how doctors should manage antiarrhythmic drugs (AADs) before heart procedures to ensure they have accurate test results and successful outcomes. It found specific timeframes for stopping different AADs before procedures for conditions like atrial fibrillation and ventricular tachycardia, providing a detailed guide on how to adjust these timeframes based on individual patient factors. This is important because it helps standardize practices, making procedures safer and more effective. Who this helps: This helps doctors and patients undergoing heart procedures.

Plain English
This study looked at the use of one versus two local anesthetics during a specific treatment called percutaneous stellate ganglion block (PSGB) for people experiencing severe heart rhythm problems known as electrical storm. Researchers examined 422 PSGB procedures and found that using two types of anesthetics led to better results, with 85% of patients having their heart rhythm fully controlled after one hour, compared to 70% for those who only received one anesthetic. Although using two anesthetics resulted in slightly more minor complications (8% compared to 2%), it didn't significantly increase serious risks. Who this helps: This benefits patients with severe heart rhythm issues.

Plain English
This study looked at a specific heart imaging pattern called ring-like late gadolinium enhancement (RL-LGE) in patients with arrhythmogenic cardiomyopathy, a condition that affects the heart's ability to pump effectively. Researchers found that among 149 patients, 49% showed this pattern, especially in those with a specific genetic background. RL-LGE was linked to a higher risk of serious heart events: 24 patients experienced life-threatening issues, and 67% of those had the RL-LGE pattern, making it a significant predictor for risk. Who this helps: This research helps patients with arrhythmogenic cardiomyopathy and their doctors by identifying those at higher risk for dangerous heart events.

Plain English
This study looks at how to better categorize heart muscle diseases, known as cardiomyopathies, by combining genetic and biological factors with how the disease affects the heart's structure and function. The researchers propose a new classification system that includes three types: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic cardiomyopathy. This matters because a clearer understanding of these diseases can lead to more tailored treatments and improved patient outcomes. Who this helps: Patients with cardiomyopathies and their doctors.

Plain English
This study examined the effectiveness of a type of defibrillator called a subcutaneous implantable cardioverter defibrillator (S-ICD) in patients and used a scoring system called the PRAETORIAN score to predict its success. Out of 1,253 patients, 95.7% had a PRAETORIAN score below 90, indicating a low risk of the device failing to deliver a lifesaving shock. The research found that body mass index (BMI) was the only factor that predicted a higher risk score, with patients having a BMI under 25 consistently showing low scores. Who this helps: This benefits patients with heart conditions who may need an S-ICD, ensuring more successful outcomes for those with normal weights.

Plain English
This study looked at how to evaluate the risk of dangerous heart rhythms in people with arrhythmogenic cardiomyopathy (ACM), a heart condition that can lead to serious issues. Researchers found that using a combination of clinical exams, genetic testing, and online risk calculators can help identify patients at higher risk for complications, but doctors' expertise is still crucial in making treatment decisions. Regularly updating risk assessments is also important since ACM can change over time. Who this helps: This benefits patients with ACM and their doctors.

Plain English
This study introduces a new way to classify heart conditions known as cardiomyopathies into three main groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic. By looking at both the physical structure of the heart and the underlying biology, the researchers aim to improve how doctors diagnose and treat these conditions. This is important because better diagnosis and treatment can lead to improved health outcomes for patients with heart disease. Who this helps: This helps patients with cardiomyopathies and their doctors.

Plain English
This study looked at whether being physically active or playing sports affects the safety of subcutaneous implantable cardioverter defibrillator (S-ICD) devices in younger patients. Out of 602 participants, only 3.8% experienced issues related to the device, and being active did not lead to more complications or shocks from the device. This finding is important because it shows that young patients with S-ICDs can safely maintain an active lifestyle without increasing their risk of problems related to their heart devices. Who this helps: This helps patients with S-ICDs and their doctors understand that staying active is safe for their health.

Plain English
This study looked at how well healthcare systems in Europe help patients with atrial fibrillation (AF) change their lifestyle and manage risk factors. Out of 258 healthcare professionals surveyed, nearly 40% said their systems poorly support lifestyle changes, and most felt unprepared to address issues like mental health and sleep problems. Although 70% of AF patients could gain from exercise programs, only 10% actually get referred to these services, highlighting a major gap in care. Who this helps: This research benefits patients with atrial fibrillation who need better support for lifestyle changes and healthcare providers aiming to improve care.

Plain English
This study looked at the long-term effectiveness of a special heart device called the subcutaneous implantable cardioverter-defibrillator (S-ICD) in patients with Brugada syndrome, a condition that can lead to serious heart issues. Researchers followed 450 patients for an average of about 4.5 years and found that only 3% required electric shocks from the device to correct heart rhythms, with a 90% success rate on the first shock. With a low complication rate of 4%, the S-ICD is shown to be a safe and effective option for these patients, offering a better alternative to other devices that can cause more problems over time. Who this helps: This benefits patients with Brugada syndrome who are at risk of sudden cardiac death.

Plain English
This study looked at patients with a type of heart condition called Brugada syndrome who are not considered at high risk, focusing on those with atrial fibrillation (AF). Researchers found that 40.8% of the 686 patients had AF, but this did not lead to a higher annual risk of dangerous heart rhythms. However, those who developed AF at an early age (under 20 years) faced a much higher risk of dangerous heart rhythms, and patients with AF were more likely to experience sick sinus syndrome and strokes, which occurred in 2.5% of them. Who this helps: This research benefits patients with Brugada syndrome and their doctors by identifying important risks associated with atrial fibrillation.

Plain English
This study looked at the effectiveness of the Shanghai score system for predicting risks in patients with a specific heart condition called drug-induced type 1 Brugada Syndrome (BrS). Researchers analyzed 698 patients and found that 2.9% of them experienced serious heart issues like sudden cardiac death over an average follow-up of about 4.5 years. Specifically, patients with a higher Shanghai score had a greater chance of these dangerous events, making this scoring system a useful tool for identifying patients at higher risk. Who this helps: This benefits both patients with Brugada Syndrome and their doctors by improving risk assessment and management strategies.

Plain English
This study focused on the risk of infection associated with cardiac implantable electronic devices (CIEDs), which are important for treating heart rhythm issues. It reviewed strategies to prevent infections, finding that following specific guidelines can significantly reduce the risk. For instance, measures like using antibiotic prophylaxis can lower infection rates, which is crucial since infections can worsen patients' health and increase healthcare costs. Who this helps: This benefits patients with CIEDs and the doctors who care for them.

Plain English
This research focused on understanding how severe different complications from atrial fibrillation (AF) ablation are perceived by European heart specialists. A survey of 300 doctors showed that they ranked unexplained death, atrio-oesophageal fistula, and procedural stroke as the most serious complications, scoring them at 90, 92, and 80 out of 100, respectively. This study is important because it creates a standardized scoring system that can help compare safety across different AF ablation procedures. Who this helps: This benefits patients undergoing AF ablation and their doctors.

Plain English
This study looked at how using a special type of CT scan before a procedure called transvenous lead extraction (TLE) can help predict difficulties and complications during the procedure. Researchers found that complicated procedures happened in about 21% of patients, and those with fibrosis (scarring) longer than 40 mm on the CT scan were more likely to face complications. Additionally, 37% of procedures were deemed complex, with longer fibrosis lengths and lead calcifications making these procedures more challenging. The findings demonstrate that CT scans can help doctors assess risks and plan better for TLE procedures. Who this helps: This helps doctors and patients undergoing TLE by improving safety and outcomes.

Plain English
This study examined the relationship between a thinner heart muscle layer and heart function in patients with a condition called isolated left ventricular non-compaction (LVNC) cardiomyopathy. Researchers found that patients with reduced heart function (ejection fraction) had a compact heart muscle layer that was thinner compared to those with normal heart function—specifically, two or more segments of the heart wall were under 5 mm thick, which accurately identified reduced heart function with 100% sensitivity. This is important because it helps identify patients at risk for heart dysfunction based on their heart's structure. Who this helps: This helps patients with LVNC and their doctors better understand heart function and potential risks.

Plain English
This study looked at a 74-year-old man who experienced sudden chest pain after getting a pacemaker. The doctors discovered that the pacemaker had caused serious injuries, including damage to his heart and a major artery, leading to significant bleeding. They treated him successfully, and he had a good recovery over the next two years, which emphasizes the need for doctors to consider possible complications like this when patients have chest pain soon after pacemaker surgery. Who this helps: This helps doctors and patients by highlighting the risks associated with pacemaker implantation.

Plain English
This study looked at the long-term health outcomes for patients who developed a specific heart rhythm problem, known as drug-induced type 1 Brugada syndrome. Researchers followed 606 patients for over five years and found that only 3.1% experienced serious heart issues, with a low annual event rate of 0.5%. The study highlighted that a genetic mutation (called SCN5A) is a strong predictor of these serious problems, and those who experienced fainting spells had worse outcomes. Who this helps: This information benefits doctors and patients with drug-induced Brugada syndrome by improving risk assessment and management strategies.

Plain English
This study looked at a material called 4H-SiC, used in electronic devices, to understand how defects affect its performance. The researchers found that even when the material seemed uniform, the time it took for energy carriers to recombine varied based on where you measured on the material, showing a problematic range from 0.5 to 3.2 nanoseconds in carrier lifetime. This is important because it means the quality of the material can significantly affect device performance, potentially leading to inefficiencies in electronics. Who this helps: This helps engineers and manufacturers of electronic devices.

Plain English
This study looked at patients with advanced heart failure who used both a left ventricular assist device (LVAD) and a subcutaneous implantable cardioverter defibrillator (S-ICD). Out of 30 patients, 21 experienced some degree of electromagnetic interference, but 90% remained eligible for the S-ICD. This is important because it shows that most patients can safely use both devices together, although doctors need to be cautious about potential issues related to electromagnetic interference that could affect how the devices work. Who this helps: Patients with advanced heart failure who require mechanical support for their hearts.

Plain English
This study looked at the costs associated with atrial fibrillation (AF), a common heart condition that affects more people as the population ages. It found that the average annual cost for treating a patient with AF is around €9,409 (about $13,333), with the largest expenses coming from hospital stays and complications like strokes. Understanding these costs is important because it highlights the need for better management of additional health issues in AF patients, which can lower both health risks and medical expenses. Who this helps: This helps patients with atrial fibrillation and their healthcare providers.

Plain English
The study focused on patients with mitral valve prolapse (MVP), a heart condition that can sometimes lead to irregular heartbeats called ventricular arrhythmias (VA), even without significant valve leakage. Among 108 patients with MVP, 62 (57%) experienced VA, and those patients had more severe heart tissue and structural changes, including a longer mitral annulus disjunction (average of 6.0 mm vs. 3.2 mm) and a higher prevalence of heart tissue scarring (79% vs. 52%). This research is important because it helps identify which patients with MVP are at greater risk for serious heart issues, guiding better monitoring and treatment. Who this helps: This helps patients with mitral valve prolapse and their doctors in managing their health.

Plain English
This study looked at how effective implantable loop recorders (ILRs) are for monitoring heart rhythms in patients with Brugada syndrome (BrS). Out of 370 patients followed for an average of three years, nearly 31% experienced heart rhythm problems, with the most common issues being atrial and bradyarrhythmias, while ventricular arrhythmias were less frequent. The findings are important because they show that ILRs can identify significant arrhythmias in many patients, leading to necessary treatments in about 70% of those affected. Who this helps: This benefits patients with Brugada syndrome and their doctors by improving their ability to detect and treat heart rhythm issues.

Plain English
This study explored new methods of pacing the heart to improve treatment for patients with conduction system problems. Researchers found that conduction system pacing (CSP) can reduce heart rhythm disruptions better than traditional methods, with a significant decrease in the duration of QRS waves—an electrical signal indicating heart activity. Many doctors in Italy are now choosing CSP techniques, especially left bundle branch pacing, because it's easier to perform and works effectively. Who this helps: This benefits patients with heart rhythm issues and doctors providing cardiac care.

Plain English
The study looked at how doctors define and manage a specific heart condition called arrhythmia-induced cardiomyopathy (AiCM), which happens when heart rhythm problems lead to weak heart function. Out of 206 heart specialists surveyed, 67% agreed that AiCM is linked to reduced heart function due to arrhythmia, but only 35% could pinpoint how much heart function decline confirms the condition. This research shows that doctors have different approaches to treating AiCM, indicating the need for clearer guidelines to ensure patients receive better and more consistent care. Who this helps: This helps patients with heart conditions and their doctors.

Plain English
This study looked at the safety and effectiveness of removing special heart leads used for pacing in patients, involving data from 341 individuals at 10 different hospitals worldwide. The results were impressive, with 99% of the extraction procedures successful and only a 2.1% complication rate. This is important because it shows that removing these pacing leads is generally safe and that reimplanting them afterward is very successful, helping to improve treatment options for patients with heart rhythm issues. Who this helps: Patients with heart rhythm disorders needing lead removal and replacement.

Plain English
This study looked at how often patients experienced worsening of tricuspid valve regurgitation (TR) after a procedure called transvenous lead extraction (TLE), which is used to remove implanted heart leads. Out of 158 patients, 5.7% had a significant increase in TR severity, especially those with longer lead implant durations and certain types of leads. This is important because severe worsening of TR can significantly raise the risk of dying, highlighting the need for doctors to be careful when performing this procedure. Who this helps: This helps patients undergoing lead extraction and their doctors by improving awareness of potential complications.

Plain English
This study looked at how genetic testing for heart conditions is being used across Europe, involving responses from 357 healthcare professionals in 69 countries. It found that 39% of those surveyed either didn't offer genetic testing or did so very infrequently, and 78% reported problems accessing these tests, mainly due to a lack of specialized units or issues with insurance coverage. This is important because genetic testing can help diagnose heart diseases accurately, guide treatment, and advise family members about their risk. Who this helps: Patients with inherited heart conditions and their families benefit from improved access to genetic testing and information.

Plain English
This study examined a rare heart condition called left ventricular non-compaction (LVNC), which affects the structure of the heart muscle. It was found that the traditional way of diagnosing LVNC might not be specific enough, as the traits used to identify it can appear in other heart issues too. New insights suggest that the problem might actually be related to the underdevelopment of a specific part of the heart wall, which affects how well the heart pumps blood. Who this helps: This research benefits doctors and patients with heart conditions, especially those dealing with LVNC.

Plain English
This study compared two methods for accessing veins to place devices that help regulate heart rhythm. It found that using ultrasound to guide the procedure reduces the time needed to access the vein and limits radiation exposure, while also keeping complications low. Specifically, the ultrasound method decreased the risk of accidental artery punctures, making it a safer option than the traditional X-ray-guided approach. Who this helps: This helps patients receiving heart devices and doctors performing these procedures.

Plain English
This study looked at patients with inherited arrhythmia syndromes (IAS) who also experienced atrial arrhythmias (AAs), a type of irregular heartbeat. Researchers found that 82% of these patients had atrial fibrillation, and the annual risk of serious heart issues was 1.4%, which doubled for those who had AAs before age 20. Understanding these patterns is important because it helps identify at-risk patients and guide their treatment plans. Who this helps: This benefits patients with inherited arrhythmia syndromes and their doctors.

Plain English
This study looked at how heating silicon carbide (SiC) materials at very high temperatures (between 1,600 and 2,000 degrees Celsius) affects their quality for use in electronic devices. Researchers found that heating caused some areas of the material to turn into graphite, starting at 1,650 degrees, which led to defects that reduced the efficiency of the devices made from these materials. This matters because improving the quality of SiC can lead to better-performing electronics that can operate at high temperatures and voltages. Who this helps: This benefits manufacturers of high-temperature electronic devices.

Plain English
This study looked at infections related to cardiac implantable electronic devices (like pacemakers) and how different factors affect patient survival. Researchers tracked 157 patients over ten years and found that infection from Staphylococcus aureus bacteria was present in 32.5% of cases, leading to worse outcomes, especially in patients with "cold closed pocket" infection patterns. They also created a scoring system to better predict mortality risk, which could help identify patients who need more aggressive treatment. Who this helps: This helps patients with cardiac device infections and their doctors in tailoring treatment strategies.

Plain English
This study compared two types of life-saving devices, the subcutaneous ICD (S-ICD) and the transvenous ICD (TV-ICD), in patients with hypertrophic cardiomyopathy (HCM) who are at risk of sudden cardiac death. The researchers found that S-ICD patients had a significantly lower risk of receiving both appropriate (68% less likely) and inappropriate (56% less likely) shocks from their devices over five years and also experienced fewer serious complications related to the device. This matters because it indicates that S-ICDs may be a safer option for these patients, potentially leading to better quality of life. Who this helps: This helps patients with hypertrophic cardiomyopathy and their doctors in choosing safer device options.

Plain English
This study looked at how doctors manage the risk of blood clots in patients undergoing procedures on the right side of the heart. It found that only 34% of doctors routinely prescribe medications to prevent blood clots during these procedures, and only 25% do so after patients go home. Notably, 13% of doctors reported seeing at least one case of deep vein thrombosis (DVT) and 9% reported pulmonary embolism (PE) linked to these procedures in the past year, highlighting a potential risk associated with a lack of consistent prevention strategies. Who this helps: This information is important for patients undergoing right-sided heart procedures and their doctors.

Plain English
This study focused on how well isoprenaline works for patients with unstable third-degree atrioventricular block, a serious heart condition that can lead to fainting or even death. Researchers found that isoprenaline was effective for 84% of patients, compared to only 31% for dopamine, making isoprenaline a much better option. This is important because it suggests a safer and more effective treatment while waiting for a permanent pacemaker, which can significantly improve patient outcomes. Who this helps: This benefits patients experiencing unstable heart conditions and their doctors.